Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Sep'24
Net Sales
160.93
145.30
119.85
167.41
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
160.93
145.30
119.85
167.41
0.00
Raw Material Cost
118.91
100.44
91.08
125.01
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-7.35
4.41
-6.66
-1.23
0.00
Employee Cost
8.15
8.30
7.63
9.70
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.72
3.67
3.64
4.59
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
11.16
6.14
7.17
12.09
0.00
Total Expenditure (Excl Depreciation)
134.59
122.96
102.86
150.16
0.00
Operating Profit (PBDIT) excl Other Income
26.34
22.34
16.99
17.25
0.00
Other Income
0.00
0.00
0.00
0.00
0.00
Operating Profit (PBDIT)
26.34
22.34
16.99
17.25
0.00
Interest
10.55
7.73
6.53
8.15
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
15.79
14.61
10.46
9.10
0.00
Depreciation
1.78
1.89
1.42
1.84
0.00
Profit Before Tax
14.00
12.71
9.04
7.26
0.00
Tax
3.52
3.27
2.27
1.26
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10.48
9.43
6.77
6.00
0.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
10.48
9.43
6.77
6.00
0.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10.48
9.43
6.77
6.00
0.00
Equity Capital
4.72
4.72
4.72
4.72
4.72
Face Value
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
22.2
19.98
14.34
12.71
0.0
Diluted Earnings per share
22.19
19.98
14.33
12.71
0.0
Operating Profit Margin (Excl OI)
16.47%
15.56%
14.23%
10.43%
0.0%
Gross Profit Margin
9.87%
10.17%
8.76%
5.5%
0.0%
PAT Margin
6.55%
6.57%
5.67%
3.63%
0.0%
Public Share Holdings (%)
51.07%
51.07%
51.07%
51.07%
50.84%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 27.18% vs 41.15% in Mar 2025
Standalone Net Profit
YoY Growth in quarter ended Mar 2026 is 56.58% vs 39.72% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 67.03% vs 56.13% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 77.79% vs 86.50% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Fredun Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
160.93
135.41
25.52
18.85%
Other Operating Income
0.00
0.00
0.00
Total Operating income
160.93
135.41
25.52
18.85%
Raw Material Cost
118.91
67.45
51.46
76.29%
Purchase of Finished goods
0.00
20.55
-20.55
-100.00%
(Increase) / Decrease In Stocks
-7.35
-4.68
-2.67
-57.05%
Employee Cost
8.15
16.95
-8.80
-51.92%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
3.72
-0.01
3.73
37,300.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
11.16
13.14
-1.98
-15.07%
Total Expenditure (Excl Depreciation)
134.59
113.40
21.19
18.69%
Operating Profit (PBDIT) excl Other Income
26.34
22.01
4.33
19.67%
Other Income
0.00
14.55
-14.55
-100.00%
Operating Profit (PBDIT)
26.34
36.56
-10.22
-27.95%
Interest
10.55
0.38
10.17
2,676.32%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
15.79
36.18
-20.39
-56.36%
Depreciation
1.78
2.48
-0.70
-28.23%
Profit Before Tax
14.00
33.70
-19.70
-58.46%
Tax
3.52
8.53
-5.01
-58.73%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
10.48
25.17
-14.69
-58.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
10.48
25.17
-14.69
-58.36%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10.48
25.17
-14.69
-58.36%
Equity Capital
4.72
94.00
-89.28
-94.98%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
22.20
0.27
21.93
8,122.22%
Diluted Earnings per share
22.19
0.27
21.92
8,118.52%
Operating Profit Margin (Excl OI)
16.47%
16.25%
0.00
0.22%
Gross Profit Margin
9.87%
26.72%
0.00
-16.85%
PAT Margin
6.55%
18.59%
0.00
-12.04%
Public Share Holdings (%)
51.07%
0.00%
51.07
51.07%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 210.41 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 31.56% vs 11.38% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 27.18% vs 41.15% in Mar 2025
Quarterly - Standalone Net Profit
Standalone Net Profit 11.07 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 5.63% vs 7.71% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 56.58% vs 39.72% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.13 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 10.59% vs 17.85% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 67.03% vs 56.13% in Mar 2025
Quarterly - Interest
Interest 14.49 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 37.35% vs 36.48% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 77.79% vs 86.50% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.84%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
